✦ LIBER ✦

494 Novel Prognostic and Predictive Germline Genetic Markers of Overall Survival in Renal Cell Carcinoma Patients Treated with Sorafenib

✍ Scribed by Crona, D.; Skol, A.; Ahsan, H.; Pena, C.; Innocenti, F.

Book ID: 123025004
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 59 KB
Volume: 48
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(12)72292-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

494Mitotic catastrophe marker cyclin B1

494Mitotic catastrophe marker cyclin B1 in renal cell carcinoma correlates with stage, metastasis and survival of patients

✍ S.O. Ikuerowo; M. Kuczyk; S. Machtens; M. Mengel; U. Jonas; J. Serth 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB

LYMPHATIC SPACE INVASION PREDICTS METAST

LYMPHATIC SPACE INVASION PREDICTS METASTATIC BEHAVIOR IN PATIENTS WITH RENAL CELL CARCINOMA AND MAY BE AN INDEPENDENT PROGNOSTIC FACTOR FOR OVERALL SURVIVAL

✍ Herrera, Loren P; Reis, Isildinha; Bird, Vincent G; Jorda, Merce 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 49 KB

MP57-07 ELEVATED BLOOD EOSINOPHIL LEVEL

MP57-07 ELEVATED BLOOD EOSINOPHIL LEVEL PREDICTS BETTER RESPONSE AND LONGER SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED BY SORAFENIB

✍ Zhang, Hai-liang; Wang, Hongkai; Ye, Ding-wei 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 673 KB

7120 A retrospective review of treatment

7120 A retrospective review of treatment discontinuation and survival in patients with advanced renal cell carcinoma treated with sunitinib or sorafenib

✍ Liu, Z.; Zheng, J.; Riedel, A.A.; Johnson, J.; Burke, J. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

1765 NEPHRECTOMY IMPROVES OVERALL SURVIV

1765 NEPHRECTOMY IMPROVES OVERALL SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA IN CASES OF FAVOURABLE MSKCC OR ECOG PROGNOSTIC FEATURES

✍ CRÉPEL, Maxime; Joly, Florence; Ravaud, Alain; Guy, Laurent; Bernhard, Jean-Chri 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 115 KB

Overall survival and good tolerability o

Overall survival and good tolerability of long-term use of sorafenib after cytokine treatment: final results of a phase II trial of sorafenib in Japanese patients with metastatic renal cell carcinoma

✍ Seiji Naito; Taiji Tsukamoto; Masaru Murai; Koichi Fukino; Hideyuki Akaza 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB